Silicon Biosystems
Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.
Menarini Silicon Biosystems Publishes Single-Cell WGA Liquid Biopsy Workflow, Eyes Clinical Market
Premium
The firm is also working on expanding its CTC capture capabilities beyond epithelial cells and will present multiple myeloma applications at an upcoming conference.
Menarini-Silicon Biosystems Completes Acquisition of Janssen CTC System
The purchase from Janssen of a liquid biopsy test for circulating tumor cells marks Menarini-Silicon's entry into the US diagnostics market.
Menarini-Silicon Biosystems to Acquire Cellsearch CTC Platform From Janssen Diagnostics
Cellsearch is the only FDA-cleared circulating tumor cell test and is used to help manage patients with metastatic breast, prostate, and colorectal cancers.
Macrogen, Silicon Biosystems Menarini Ink Deal to Co-Develop CLIA-Certified Cancer Assays
They plan to combine Silicon’s DEPArray digital-sorting technology with Macrogen’s NGS systems to develop genomic tests for different cancers.